Other
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: > Other
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Subheadings
Products classified under HTS 3002.49.00
Inactivated Polio Vaccine (IPV)
Inactivated poliovirus vaccine contains killed poliovirus strains to stimulate immunity without causing disease. It falls under HTS 3002.49.00 as a vaccine, which is an immunological product for prophylactic use against poliomyelitis. This product is typically administered via injection.
Rabies Vaccine for Human Use
Human diploid cell rabies vaccine is a purified, inactivated vaccine derived from rabies virus grown in human cells. Classified under HTS 3002.49.00 as 'other' vaccines for post-exposure prophylaxis and pre-exposure immunization. It is a key product for preventing rabies infection.
Yellow Fever Vaccine (17D Strain)
Live attenuated yellow fever vaccine (17D strain) is grown in chick embryo cells for immunization against yellow fever virus. It is classified in HTS 3002.49.00 as an 'other' vaccine product for prophylactic use. Requires international certificate for travel.
Cholera Vaccine (Oral Recombinant)
Dukoral oral cholera vaccine contains inactivated Vibrio cholerae bacteria and recombinant B subunit for mucosal immunity. Falls under HTS 3002.49.00 as an 'other' vaccine via biotechnological processes. Administered as oral suspension for traveler's protection.
Japanese Encephalitis Vaccine (Inactivated)
Ixiaro vaccine is an inactivated Vero cell-derived Japanese encephalitis virus vaccine for adults and children. Classified under HTS 3002.49.00 as 'other' vaccines for travel-related prophylaxis. Two-dose regimen provides long-term immunity.
Tick-Borne Encephalitis Vaccine
FSME-Immun vaccine is inactivated tick-borne encephalitis virus cultured in chick cells for European tick protection. HTS 3002.49.00 covers it as 'other' vaccines obtained by biotechnological processes. Booster doses recommended periodically.
Q Fever Vaccine (Inactivated)
Q-Vax inactivated whole-cell Coxiella burnetii vaccine for high-risk occupational use like veterinarians. Under HTS 3002.49.00 as 'other' vaccines from micro-organisms. Skin testing required prior to administration.
Anthrax Vaccine Adsorbed (AVA)
BioThrax anthrax vaccine uses protective antigen from Bacillus anthracis adsorbed to alum for protective immunity. Classified HTS 3002.49.00 as 'other' toxin-derived vaccines. Used in military and emergency stockpiles.
Shigella Flexneri Vaccine (Oral Live)
FlexLev live attenuated Shigella flexneri 2a oral vaccine strain Sc4020 for military and traveler use. HTS 3002.49.00 for 'other' cultures of micro-organisms as vaccines. Single-dose sachet delivery.
Dengue Vaccine (Tetravalent Live Attenuated)
Dengvaxia chimeric yellow fever-dengue tetravalent live vaccine for seropositive individuals. Under HTS 3002.49.00 as 'other' vaccines from micro-organisms. Three-dose schedule over 12 months.
Norovirus Vaccine (Virus-Like Particles)
Bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate using recombinant technology. HTS 3002.49.00 covers biotechnological immunological products as 'other' vaccines. Intramuscular administration.
Paratyphoid Vaccine (Oral Live Attenuated)
Live attenuated Salmonella Paratyphi A oral vaccine for combined typhoid-paratyphoid protection. Classified HTS 3002.49.00 as 'other' micro-organism cultures used as vaccines. Four-dose regimen.
Ross River Virus Vaccine (Inactivated)
Inactivated Ross River virus vaccine for Australian mosquito-borne arthritis prevention. Under HTS 3002.49.00 as 'other' vaccines via inactivation process. Two-dose primary series.
Zika Virus Vaccine (DNA-Based)
Recombinant DNA plasmid Zika vaccine expressing prM-E proteins for neutralizing antibodies. HTS 3002.49.00 for biotechnologically obtained 'other' vaccines. Investigational multi-dose regimen.
Chlamydia Vaccine (Recombinant)
Recombinant chlamydial major outer membrane protein vaccine for trachoma and STD prevention. Classified under HTS 3002.49.00 as 'other' immunological products from biotech processes. Adjuvanted formulation.